Monitoring and evaluation of HIV in Catalonia, getting closer to the 90-90-90 objectives
e201912118
Keywords:
HIV, CataloniaAbstract
Background: Epidemiological surveillance of HIV infection allows monitoring its incidence as well as possible epidemiological changes, allowing specific interventions to be planned and their impact monitored. The objective of this article is to describe the results of the monitoring and evaluation of the response to the HIV epidemic in Catalonia, based on data included in the Integrated System of Epidemiological Surveillance of AIDS/HIV and Sexually Transmitted Infections of Catalonia (SIVES).
Methods: A descriptive analysis of the data from the different sources of information of the SIVES was performed. The time period was defined based on the availability of data from each of the sources of information included in the analysis. The information was structured according to the conceptual representation of the cascade of HIV care, as described in the World Health Organization consolidated strategic information guidelines for HIV.
Results: Of the total of 4,849 new diagnoses notified (2012-2018), 86% were men, of these; the most frequently reported transmission group was men having sex with men with 65%. The trend in the number of new diagnoses decreased in all transmission groups. It is estimated that in 2018 there were 32,429 people living with HIV in Catalonia, of which 89% were diagnosed, of these, 83% were under follow-up in a specialized unit and 78% of them were under treatment. 73% of people in treatment had suppressed the viral load.
Conclusions: SIVES as an integrated system of different sources of strategic information allows monitoring the HIV epidemic in Catalonia and evaluating the response to it, identifying key populations and determinants to acquire HIV, as well as the barriers to which people living with HIV they face to achieve viral suppression.
Downloads
References
Pisani E, Lazzari S, Walker N, Schwartländer B. HIV surveillance: a global perspective. J Acquir Immune Defic Syndr [Internet] 2003 [cited 2019 Oct 31];32 Suppl 1:S3-11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12571509.
UN General Assembly. Political Declaration on HIV and AIDS: On the Fast-Track to Accelerate the Fight against HIV and to End the AIDS Epidemic by 2030. New York [Internet] 2016;17020(June):1–27. Available from: http://web.ua.es/es/ice/documentos/redes/2012/asesoramiento/modelo-normas-apa-bibliografia.pdf.
Junta Coordinadora del Programa de ONUSIDA. 90-90-90 Un ambicioso objetivo de tratamiento para contribuir al fin de la epidemia de Sida. OnuSida [Internet] 2015;39. Available from: http://www.unaids.org/sites/default/files/media_asset/90_90_90_es.pdf.
WHO. Person-centred HIV patient monitoring and case surveillance guidelines HIV strategic information for impact [Internet]. Geneva: 2017. Available from: http://apps.who.int/iris/bitstream/handle/10665/255702/9789241512633-eng.pdf;jsessionid=F783930BD3047F53BB02427BD836D5FD?sequence=1%0Ahttp://apps.who.int/iris/bitstream/handle/10665/255702/9789241512633-eng.pdf?sequence=1&isAllowed=y.
Comissió Interdepartamental de la Sida a Catalunya. Pla
d’ acció enfront del VIH i altres ITS 2016-2020. Barcelona: 2016.
European Centre for Disease Prevention and Control. Continuum of HIV care. Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report. Stockholm: 2019.
Centre d’Estudis Epidemiològics sobre les ITS i Sida de Catalunya (CEEISCAT). Sistema Integrat de Vigilància Epidemiològica de la SIDA/VIH/ITS a Catalunya. Badalona: 2015.
Folch C, Casabona J, Espelt A, Majó X, Meroño M, Gonzalez V et al. High prevalence and incidence of HIV and HCV among new injecting drug users with a large proportion of migrants - Is prevention failing? Subst Use Misuse 2016;51(2):250–60.
Folch C, Casabona J, Sanclemente C, Esteve A, González V, Hivits-ts G. Tendencias de la prevalencia del VIH y de las conductas de riesgo asociadas en mujeres trabajadoras del sexo en Cataluña. 2014;28(3):196–202.
The EMIS Network. EMIS-2017 - The European Men-Who-Have-Sex-With-Men Internet Survey. Key findings from 50 countries [Internet]. Stockholm: 2017. Available from: www.ecdc.europa.eu.
López-Corbeto E, González V, Lugo R, Rivaya B, Casabona J, Matas L et al. Pooling of urine samples for molecular detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium as a screening strategy among young adults in Catalonia. Enferm Infecc Microbiol Clin 2019.
Fernàndez-Lopez L, Rifà B, Pujol F, Becerra J, Pérez M, Meroño M et al. Impact of the introduction of rapid HIV testing in the Voluntary Counselling and Testing sites network of Catalonia, Spain. Int J STD AIDS [Internet] 2010 [cited 2019 Feb 18];21(6):388–91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20606218.
World Health Organization (WHO). Consolidated guidelines on HIV testing services. Geneva: World Health Organisation; July 2015 [Internet]. Geneva: 2015. Available from: http://www.who.int/hiv/pub/vct/hiv-self-testing-guidelines/en/.
World Health Organization (WHO). Compendium of good practices in the health sector response to HIV in the WHO European Region [Internet]. Geneva: 2018. Available from: http://www.euro.who.int/__data/assets/pdf_file/0004/375997/HIV-Comp-Aug-29-2.pdf.
Decret 67/2010, de 25 de maig, pel qual es regula el sistema de notificació de malalties de declaració obligatòria i brots epidèmics al Departament de Salut | DEPARTAMENT DE SALUT | Legislació | Cercador d’Informació i Documentació Oficials (CIDO) - Diputació de Barcelona [Internet]. [cited 2019 Nov 14];Available from: http://cido.diba.cat/legislacio/1342856/decret-672010-de-25-de-maig-pel-qual-es-regula-elsistema-de-notificacio-de-malalties-de-declaracio-obligatoria-ibrots-epidemics-al-departament-de-salut.
Idescat. Padró municipal d’habitants [Internet]. 2018 [cited 2019 Nov 14];Available from: https://www.idescat.cat/pub/?id=pmh.
Jaén A, Casabona J, Esteve A, Miró JM, Tural C, Ferrer E et al. [Clinical-epidemiological characteristics and antiretroviral treatment trends in a cohort of HIV infected patients. The PISCIS Project]. Med Clin (Barc) [Internet] 2005 [cited 2019 Oct 31];124(14):525–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15847748.
European Centre for Disease Prevention and Control. HIV Estimates Accuracy Tool manual. Stockholm: 2019.
La OMS reconoce el sistema catalán para el monitoreo del Sida [Internet]. [cited 2019 Nov 29];Available from: https://www.lavanguardia.com/vida/20150508/54431130785/la-oms-reconoce-el-sistema-catalan-para-el-monitoreo-del-Sida.html.
Dubois-Arber F, Jeannin A, Spencer B, Gervasoni JP, Graz B, Elford J et al. Mapping HIV/STI behavioural surveillance in Europe. BMC Infect Dis 2010;10.
Midgard H, Weir A, Palmateer N, Lo Re V, Pineda JA, Macías J et al. HCV epidemiology in high-risk groups and the risk of reinfection. J Hepatol [Internet] 2016 [cited 2019 Nov 14];65(1 Suppl):S33–45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27641987.
Joint United Nations Programme on HIV/AIDS (UNAIDS). Combination HIV Prevention: Tailoring and Coordinating Biomedical, Behavioural and Structural Strategies to Reduce New HIV INfections. Geneva: 2010.
Baral S, Logie CH, Grosso A, Wirtz AL, Beyrer C. Modified social ecological model: A tool to guide the assessment of the risks and risk contexts of HIV epidemics. BMC Public Health [Internet] 2013;13(1):1. Available from: BMC Public Health.
World Health Organization (WHO). Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations – 2016 update [Internet]. Geneva: 2016. Available from: http://apps.who.int/.
European Centre for Disease Prevention and Control WRO for E. HIV/AIDS surveillance in Europe 2018 – 2017 data. Copenhagen: 2018.
Área de vigilancia del VIH y conductas de riesgo. Vigilancia Epidemiológica del VIH y Sida en España 2017: Sistema de Información sobre Nuevos Diagnósticos de VIH y Registro Nacional de Casos de Sida [Internet]. Madrid: 2018. Available from: http://www.mscbs.gob.es/ciudadanos/enfLesiones/enfTransmisibles/Sida/vigilancia/doc/InformeVIH_SIDA_2018_21112018.pdf.
Unidad de vigilancia del VIH y conductas de riesgo. Centro Nacional de Epidemiología - Instituto de Salud Carlos III - Plan Nacional sobre el Sida - Dirección General de Salud Pública Calidad e Innovación. Estimación del continuo de atención del VIH en España, 2016. [Internet]. Madrid: 2019. Available from: https://www.mscbs.gob.es/ciudadanos/enfLesiones/enfTransmisibles/Sida/docs/ESTIMACION_DEL_CONTINUO_DE_ATENCION_DEL_VIH_EN_ESPANA.pdf.
Campbell CNJ, Ambrosioni J, Miro JM, Esteve A, Casabona J, Navarro G et al. The continuum of HIV care in Catalonia. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV 2015;27(12):1449–54.
Reyes-Urueña JM, Campbell CNJ, Vives N, Esteve A, Ambrosioni J, Tural C et al. Estimating the HIV undiagnosed population in Catalonia, Spain: descriptive and comparative data analysis to identify differences in MSM stratified by migrant and Spanish-born population. BMJ Open [Internet] 2018;8(2):e018533. Available from: http://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2017-018533.
Fernàndez-López L, Reyes-Urueña J, Agustí C, Kustec T, Serdt M, Klavs I et al. The COBATEST network: monitoring and evaluation of HIV community-based practices in Europe, 2014-2016. HIV Med 2018;19:21–6.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2019 Cristina Agustí Benito, Juliana Reyes-Urueña, Alexis Sentís Fuster, Cinta Folch Toda, Laura Fernàndez-López, Andreu Bruguera Riera, Evelin López-Corbeto, Laia Ferrer Serret, Anna Conway, Sergio Moreno Fornes, Laia Egea-Cortés, Joan Colom Farran, Jordi Casabona i Barbarà
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
